The Injectible Filler Offers an Effective, Affordable Treatment for Facial Lipoatrophy,
the Facial Wasting Associated with HIV Infection and AIDS
Pur Medical Corporation, a Canadian distributor of innovative medical and medical cosmetic
enhancement products, has introduced Bio-Alcamid™ to the Canadian market. In use in a number of European countries since
2001, Bio-Alcamid™ is an injectible solution which restores the natural fullness and contours of the face when injected
under the skin. The arrival of Bio-Alcamid™ is exceptional news to men and women suffering from Lipoatrophy, the disfiguring
condition that is often a result of the antiretroviral drugs used to treat HIV infection and AIDS.
Lipoatrophy, often referred to as facial wasting, has become the “scarlet letter” of HIV, a public
mark of HIV infection. The daily arsenal of antiretroviral drugs can take a tremendous toll on the quality of daily life causing
anemia, extreme fatigue and severe gastrointestinal problems. With the addition of the facial disfigurement of Lipoatrophy, patients
are forced to endure a constant visual reminder of the infection, essentially announcing to the world that they are HIV positive or have AIDS.
Often, the result is extreme depression, leading to a decision by some to forego the medication they require to survive.
“Until now, Canadian HIV patients living with facial Lipoatrophy have not had a viable treatment,” says Toronto
cosmetic plastic surgeon, Frank Beninger, M.D., F.R.C.S. (C). “Bio-Alcamid™ may be used in the large volume necessary to restore fat loss.
My patients have been thrilled with the results.” Mona Loufty, M.D., F.R.C.P. (C) MPH - Infectious Disease Specialist at Toronto’s Maple Leaf
Medical Clinic concurs, saying “Bio-Alcamid™ has reversed the affects of Lipoatrophy in all the patients that we have treated. It is a quick,
simple procedure with outstanding results.”
When injected under the skin, Bio-Alcamid™, an injectable gel polymer, replaces depleted fat tissue, restoring the natural
fullness and contours of the face. Unlike other injectable fillers that are commonly used in cosmetic enhancement, Bio-Alcamid™ acts like a gel prosthesis
that becomes encapsulated in a thin layer of collagen that isolates it from the host tissues. As a result, a physician can remove Bio-Alcamid™ should this ever
be desired. Bio-Alcamid has been used outside Canada in large volumes for the reconstruction of other anatomical areas, namely, buttocks, de-nervated shoulders,
and a majority of the time in Europe for facial aesthetic enhancement.
Since November, 2004, more than 1000 Bio-Alcamid treatments have been performed in Canada, under provisions of the Special Access Program, to
exceptional results. Bio-Alcamid is now approved by Health Canada’s Medical Devices Bureau, with treatments available through select, trained physicians across Canada.
Potential patients can find a physician treating Lipoatrophy with Bio-Alcamid™ by visiting www.purmedical.com or emailing
info@purmedical.com Alternatively, further information is also available from the Face Forward Foundation,
www.faceforward.ca, a non-profit foundation that supports people dealing with the physical and psychological side effects of HIV infection.
For more information, please visit the other pages within www.purmedical.com
|
